Randomized phase iii trial of adjuvant chemotherapy with s-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (acts-hnc)

HIGHLIGHTS

• who: Kiyoaki Tsukahara and colleagues from the University of Navarra, SPAIN Organization Tokyo Medical Center, Tokyo, Japan have published the article: Randomized Phase III Trial of Adjuvant Chemotherapy with S-1 after Curative Treatment in Patients with Squamous-Cell Carcinoma of the Head and Neck (ACTS-HNC), in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0116965]. February 11, 2015 of /1371/
• what: This study was designed to evaluate the effectiveness of adjuvant chemotherapy after curative treatment in patients with SCCHN.
• how: The authors conducted a phase III study to evaluate S . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.